Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-31

FDA Approved: GABLOFEN — Supplemental Application (Piramal Critical Care Inc)

View source ↗

Summary

FDA approved a supplemental application for GABLOFEN (baclofen injection) from Piramal Critical Care Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GABLOFEN (baclofen injection)

Snippet

SUPPL AP for GABLOFEN (BACLOFEN INJECTION)